OBSIDIO, INC.
Medtech · Acquired
Shear-thinning biomaterial (STB) for transcatheter embolization to control internal hemorrhage
- Grants
- $1.8M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 0 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Development of an Injectable Shear Thinning Biomaterial for the Treatment of Aneurysms | $224,962 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an Innovative Material for Transcatheter Peripheral Embolization | $290,517 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an Innovative Material for Transcatheter Peripheral Embolization | $1,247,814 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1482 | PREVEP, INC. | — | — |
| 1483 | CuePath Innovation Inc. | — | $59K |
| 1484 | Pathway Labs, Inc. | — | $3.8M |
| 1485 | OBSIDIO, INC. | — | — |
| 1486 | Nyra Medical, Inc. | — | $12M |
| 1487 | Vasc-Alert LLC | — | $163K |
| 1488 | GENECAPTURE, INC. | — | $2.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Shear-thinning Compositions For Ablationapplication
- Piezoelectric Shear-thinning Material Compositions And Methods For Useapplication
- Radioactive Shear Thinning Biomaterial Composition And Methods For Useapplication
- Shear-thinning Compositions For Ablationapplication
- Piezoelectric Shear-thinning Material Compositions And Methods For Useapplication
- Dopa Modified Gelatin For Wound Healing And Methods Of Making The Sameapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.